Merck: New pain killer safer than Vioxx
13th Nov 2006, 16:47 GMT
Number 4 U.S. drugmaker, Merck announced that its arthritis painkiller Arcoxia did not increase the risk of heart attacks, but showed mixed results in preventing gastro-intestinal bleeding, a key factor in differentiating the drug from competitors.
Merck: New pain killer safer than Vioxx related news:
- Merck: New pain drug safer than Vioxx — Financial news of the day - CNNMoney.com
- Merck: New drug safer than Vioxx — Business and financial news - CNNMoney.com
- Merck says new drug is safer than Vioxx — Cardiology News from StratCenter.com
- Vioxx successor poses heart risk in study — Boston Globe -- Business News
- Mixed reviews for Vioxx successor — MSNBC.com: Health
- Merck: Arcoxia heart risk same as Voltaren — United Press International - Health Business
- Tests of new Merck painkiller criticized — baltimoresun.com - health & science
- Vioxx-Like Drug Gets Mixed Reviews — Dayton Daily News National Headlines
- Merck & Co. drops some objections — The Oakridger:Business
- Docs Give Merck Painkiller Acroxia Mixed Reviews — FOXNews.com
Latest news from Business and financial news - CNNMoney.com:
- Why Democrats love technology
- PR mega-flack tries newspaper rescue
- Cisco snaps up networking company
- Ford layoffs humming along
- Oil drops as rally loses gas
- A startup crushes its copycats
- Hitachi, GE expand nuclear alliance
- Hot stocks: Clear Channel, Ford, IBM, more
- IBM joins in $3 billion bid for Chinese bank
- From Topflop to Topshop